--- title: "Creatd (NASDAQ:VOCL) Trading Down 7.1% - Time to Sell?" description: "Creatd (NASDAQ:VOCL) Trading Down 7.1% - Should You Sell?" type: "news" locale: "en" url: "https://longbridge.com/en/news/268547951.md" published_at: "2025-12-04T07:32:38.000Z" --- # Creatd (NASDAQ:VOCL) Trading Down 7.1% - Time to Sell? > Creatd (NASDAQ:VOCL) Trading Down 7.1% - Should You Sell? Shares of Creatd, Inc. (NASDAQ:VOCL - Get Free Report) traded down 7.1% during mid-day trading on Wednesday . The stock traded as low as $0.39 and last traded at $0.39. 8,835 shares changed hands during trading, a decline of 100% from the average session volume of 3,558,173 shares. The stock had previously closed at $0.42. ## Creatd Price Performance The company's 50-day moving average price is $0.32 and its 200-day moving average price is $0.33. The company has a market cap of $108.55 million, a P/E ratio of -0.39 and a beta of 4.05. ## About Creatd (Get Free Report) Creatd, Inc, a technology company, provides economic opportunities for creators in the United States. It operates in four segments: Creatd Labs, Creatd Partners, Creatd Ventures, and Creatd Studios. The company's flagship product is Vocal, a content distribution platform that delivers a digital publishing platform organized into niche-communities capable of hosting various rich media content. ## Featured Articles - Five stocks we like better than Creatd - What Investors Need to Know About Upcoming IPOs - 3 Stocks Poised to Benefit From Google’s AI Breakthough - Breakout Stocks: What They Are and How to Identify Them - Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026 - There Are Different Types of Stock To Invest In - 3 Stocks You’ll Wish You Bought Before 2026 *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Creatd Right Now? Before you consider Creatd, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Creatd wasn't on the list. While Creatd currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [CRTD.US - Creatd, Inc.](https://longbridge.com/en/quote/CRTD.US.md) - [CRTDD.US - CREATD INC](https://longbridge.com/en/quote/CRTDD.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Creatd Completes 1:20 Reverse Stock Split as Part of Uplisting Strategy \| CRTD Stock News | Creatd, Inc. has announced a 1-for-20 reverse stock split effective February 24, 2026, to meet national exchange listing | [Link](https://longbridge.com/en/news/276653275.md) | | Creatd, Inc. Earnings Call: Growth Amid Challenges | Creatd, Inc.'s Q3 earnings call highlighted significant growth and strategic advancements despite past challenges. Key p | [Link](https://longbridge.com/en/news/266451441.md) | | VTAK Acquires 20% Interest in Creatd’s Subsidiary Fly Flyte, Inc. \| CRTD Stock News | Creatd, Inc. announced that Catheter Precision, Inc. (VTAK) has acquired a 20% equity interest in its subsidiary, Fly Fl | [Link](https://longbridge.com/en/news/276159928.md) | | Creatd to File Quarterly Financials on Friday, November 14; Schedules Investor Conference Call for Monday, November 17 at 4:30 PM ET \| CRTD Stock News | Creatd, Inc. (OTCQB: CRTD) will file its Quarterly Report on Form 10-Q for Q3 2025 on November 14, 2025, and host an inv | [Link](https://longbridge.com/en/news/265205868.md) | | Creatd, Inc. Engages Dawson James Securities, Inc. and Lucosky Brookman, LLP to Execute Uplisting Strategy | Creatd, Inc. Engages Dawson James Securities, Inc. and Lucosky Brookman, ... | [Link](https://longbridge.com/en/news/265758923.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.